The development of stereotactic body radiotherapy in the past decade: a global perspective.
In the past 10 years, there has been an exponential increase in the incorporation of stereotactic body radiotherapy, also known as stereotactic ablative radiotherapy, into the armamentarium against various types of cancer in different settings worldwide. In this article in the 10th year anniversary issue of Future Oncology, representatives from the USA, Canada, Japan, Germany, The Netherlands, Australia and Singapore will provide individual perspectives of the development of stereotactic body radiotherapy in their respective countries.
Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA.
Simon S
SS
Lo
Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands.
Ben J
BJ
Slotman
Department of Radiation Oncology, London Regional Cancer Program, University of Western Ontario, London, ON, Canada.
Michael
M
Lock
Department of Radiation Oncology, Hiroshima University, Hiroshima, Japan.
Yasushi
Y
Nagata
Department of Radiation Oncology, University of Zurich, Zurich, Switzerland.
Matthias
M
Guckenberger
Division of Radiation Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
Shankar
S
Siva
Department of Radiation Oncology, Princess Alexandra Hospital, School of Medicine, University of Queensland, Queensland, Australia.
Matthew
M
Foote
Asian American Radiation Oncology, Singapore.
Daniel
D
Tan
Department of Radiation Oncology, Houston Methodist Hospital, Weill Cornell Medical College, Houston, TX, USA.
Bin S
BS
Teh
Department of Radiation Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Nina A
NA
Mayr
Department of Radiation Oncology, Keck School of Medicine & Norris Cancer Center at the University of Southern California, Los Angeles, CA, USA.
Eric L
EL
Chang
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Robert D
RD
Timmerman
Department of Radiation Oncology, Sunnybrook Health Sciences Center, University of Toronto, Toronto, ON, Canada.
Arjun
A
Sahgal
global; stereotactic body radiotherapy